Hydrocodone Bitartrate and Acetaminophen Oral Solution and Tafamidis, Tafamidis Meglumine
Determining the interaction of Hydrocodone Bitartrate and Acetaminophen Oral Solution and Tafamidis, Tafamidis Meglumine and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: Based on in vitro data, coadministration with tafamidis may increase the plasma concentrations and the risk of toxicity of drugs that are substrates of the transport protein breast cancer resistance protein (BCRP) (e.g., methotrexate, rosuvastatin, imatinib), uridine diphosphate glucuronosyltransferase (UGT) 1A1 (e.g., bictegravir, irinotecan, raltegravir), and/or uptake transporters OAT1 and OAT3 (organic anion transporters) (e.g., bumetanide, furosemide, lamivudine, methotrexate, oseltamivir, tenofovir, ganciclovir, adefovir, cidofovir, zidovudine, zalcitabine) at clinically relevant concentrations. The proposed mechanism is decreased clearance due to tafamidis-mediated inhibition of the corresponding transport protein. MANAGEMENT: Caution is advised if tafamidis is used concomitantly with drugs that are substrates of these transport proteins, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring should be considered whenever tafamidis is added to or withdrawn from therapy with these drugs. Patients should be monitored for the development of adverse effects. References Agencia Española de Medicamentos y Productos Sanitarios Healthcare "Centro de información online de medicamentos de la AEMPS - CIMA. Available from: URL: https://cima.aemps.es/cima/publico/home.html." ([2018]): "Product Information. Vyndaqel (tafamidis)." Pfizer U.S. Pharmaceuticals Group, New York, NY. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Professional:MONITOR: Based on in vitro data, coadministration with tafamidis may increase the plasma concentrations and the risk of toxicity of drugs that are substrates of the transport protein breast cancer resistance protein (BCRP) (e.g., methotrexate, rosuvastatin, imatinib), uridine diphosphate glucuronosyltransferase (UGT) 1A1 (e.g., bictegravir, irinotecan, raltegravir), and/or uptake transporters OAT1 and OAT3 (organic anion transporters) (e.g., bumetanide, furosemide, lamivudine, methotrexate, oseltamivir, tenofovir, ganciclovir, adefovir, cidofovir, zidovudine, zalcitabine) at clinically relevant concentrations. The proposed mechanism is decreased clearance due to tafamidis-mediated inhibition of the corresponding transport protein.
MANAGEMENT: Caution is advised if tafamidis is used concomitantly with drugs that are substrates of these transport proteins, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring should be considered whenever tafamidis is added to or withdrawn from therapy with these drugs. Patients should be monitored for the development of adverse effects.
- Agencia Española de Medicamentos y Productos Sanitarios Healthcare "Centro de información online de medicamentos de la AEMPS - CIMA. Available from: URL: https://cima.aemps.es/cima/publico/home.html." ([2018]):
- "Product Information. Vyndaqel (tafamidis)." Pfizer U.S. Pharmaceuticals Group, New York, NY.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: acetaminophen / hydrocodone
Brand name: Anexsia, Dolorex Forte, Hycet, Liquicet, Lorcet, Lortab, Maxidone, Norco, Polygesic, Stagesic, Vicodin, Xodol, Zamicet, Zydone, Verdrocet, Lortab 10/325, Lortab 5/325, Lortab 75/325, Lortab Elixir, Zyfrel
Synonyms: Acetaminophen and Hydrocodone, Hydrocodone and Acetaminophen
Generic Name: tafamidis
Brand name: Vyndamax, Vyndaqel
Synonyms: Tafamidis
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocodone Bitartrate and Acetaminophen Oral Solution-Tafenoquine
- Hydrocodone Bitartrate and Acetaminophen Oral Solution-Tafenoquine (Malaria Prevention)
- Hydrocodone Bitartrate and Acetaminophen Oral Solution-Tafenoquine (Prevention of Malaria Relapse)
- Hydrocodone Bitartrate and Acetaminophen Oral Solution-Tafenoquine Succinate (Arakoda)
- Hydrocodone Bitartrate and Acetaminophen Oral Solution-Tafenoquine Succinate (Krintafel)
- Hydrocodone Bitartrate and Acetaminophen Oral Solution-Tafinlar
- Tafamidis, Tafamidis Meglumine-Hydrocodone Extended-Release Capsules
- Tafamidis, Tafamidis Meglumine-Hydrocodone Extended-Release Tablets
- Tafamidis, Tafamidis Meglumine-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Tafamidis, Tafamidis Meglumine-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Tafamidis, Tafamidis Meglumine-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Tafamidis, Tafamidis Meglumine-Hydrocortisone